Expertise in
27
conditions

Dr. Marina M. Roytman

Internal Medicine
Office
290 N Wayte Ln Ste 2300, 
Fresno, CA 
Offers Telehealth
Expertise in
27
conditions
Office
290 N Wayte Ln Ste 2300, 
Fresno, CA 

Overview

Marina Roytman is a primary care provider, practicing in Internal Medicine in Fresno, California.

Dr. Roytman is highly rated in 27 conditions, according to our data. Her clinical expertise encompasses Hepatitis, Non-Alcoholic Fatty Liver Disease, Nonalcoholic Steatohepatitis (NASH), Liver Transplant, and Endoscopy.

She is actively involved in clinical research, co-authoring 52 peer reviewed articles and participating in 3 clinical trials.

Specialties

Internal Medicine

Licenses

Internal Medicine in CA

Hospital Affiliations

Community Regional Medical Center
Clovis Community Medical Center
Adventist Health Hanford

Languages Spoken

English
Russian
Spanish

Gender

Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Alignment Health Plan
  • MEDICARE MAPD
  • MEDICARE SNP
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Health Net

Accepted plan types not found. Please verify directly with the provider.

Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Kaiser Permanente
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER MEDICARE
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 9 Less Insurance Carriers -

Locations

Office
290 N Wayte Ln Ste 2300, Fresno, CA 93701

Additional Areas of Focus

Dr. Roytman has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Non-Alcoholic Fatty Liver Disease
Nonalcoholic Steatohepatitis (NASH)

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

A Phase 3, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Obeticholic Acid in Subjects With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis
A Phase 3, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Obeticholic Acid in Subjects With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis
Enrollment Status: Completed
Publish Date: October 23, 2023
Intervention Type: Drug
Study Drug: Obeticholic acid
Study Phase: Phase 3
A Phase 3, Matrix Design, Partially Double-Blind, Randomized Study of the Efficacy and Safety of 50 mg Lonafarnib/100 mg Ritonavir BID With and Without 180 mcg PEG IFN-alfa-2a for 48 Weeks Compared With PEG IFN-alfa-2a Monotherapy and Placebo Treatment in Patients Chronically Infected With Hepatitis Delta Virus Being Maintained on Anti-HBV Nucleos(t)Ide Therapy (D-LIVR)
A Phase 3, Matrix Design, Partially Double-Blind, Randomized Study of the Efficacy and Safety of 50 mg Lonafarnib/100 mg Ritonavir BID With and Without 180 mcg PEG IFN-alfa-2a for 48 Weeks Compared With PEG IFN-alfa-2a Monotherapy and Placebo Treatment in Patients Chronically Infected With Hepatitis Delta Virus Being Maintained on Anti-HBV Nucleos(t)Ide Therapy (D-LIVR)
Enrollment Status: Completed
Publish Date: April 14, 2023
Intervention Type: Drug
Study Drugs: Lonafarnib, Ritonavir, PEG IFN-alfa-2a
Study Phase: Phase 3
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of Emricasan, an Oral Caspase Inhibitor, in Subjects With Decompensated Non-Alcoholic Steatohepatitis (NASH) Cirrhosis
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of Emricasan, an Oral Caspase Inhibitor, in Subjects With Decompensated Non-Alcoholic Steatohepatitis (NASH) Cirrhosis
Enrollment Status: Unknown
Publish Date: March 19, 2019
Intervention Type: Drug
Study Drug: Emricasan
Study Phase: Phase 2
View 2 Less Clinical Trials

52 Total Publications

Palliative Care Intervention for Patients With End-Stage Liver Disease: A Cluster Randomized Clinical Trial.
Palliative Care Intervention for Patients With End-Stage Liver Disease: A Cluster Randomized Clinical Trial.
Journal: JAMA internal medicine
Published: April 13, 2026
Similar Doctors
Expertise in
41
conditions
Dr. Dickran H. Gulesserian
Internal Medicine
Expertise in
41
conditions
Dr. Dickran H. Gulesserian
Internal Medicine

Spruce Multispeciatly Group

1275 E Spruce Ave Ste 101, 
Fresno, CA 
 (7.9 miles away)
559-439-5757
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Dickran Gulesserian is a primary care provider, practicing in Internal Medicine in Fresno, California. Dr. Gulesserian is highly rated in 41 conditions, according to our data. His clinical expertise encompasses Acute Coronary Syndrome, Hypertension, Familial Hypertension, Bone Graft, and Vertebroplasty.

Expertise in
112
conditions
Dr. Jose L. Bautista
Internal Medicine
Expertise in
112
conditions
Dr. Jose L. Bautista
Internal Medicine

Office

4836 N 1st St, 
Fresno, CA 
 (4.0 miles away)
800-300-6664
Languages Spoken:
English, Spanish
See accepted insurances
Offers Telehealth

Jose Bautista is a primary care provider, practicing in Internal Medicine in Fresno, California. Dr. Bautista is highly rated in 112 conditions, according to our data. His clinical expertise encompasses Type 2 Diabetes (T2D), Glucocorticoid-Remediable Aldosteronism, Hypertension, and Familial Hypertension.

Expertise in
24
conditions
Dr. Parminder K. Janda
Internal Medicine
Expertise in
24
conditions
Dr. Parminder K. Janda
Internal Medicine

Office

7078 N Maple Ave Ste 101, 
Fresno, CA 
 (7.9 miles away)
559-494-4700
Languages Spoken:
English, Hindi, Lahnda
See accepted insurances
Offers Telehealth

Parminder Janda is a primary care provider, practicing in Internal Medicine in Fresno, California. Dr. Janda is highly rated in 24 conditions, according to our data. Her clinical expertise encompasses Hypertensive Heart Disease, Enlarged Liver, Pediatric Myocarditis, and Nephrosclerosis.

Frequently Asked Questions about Dr. Marina M. Roytman

How do I make an appointment with Dr. Marina M. Roytman?

You can book an appointment with Dr. Marina M. Roytman by calling their office at 866-342-6012. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Marina M. Roytman a top-rated expert for Hepatitis?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Marina M. Roytman is classified as an Elite expert for Hepatitis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Marina M. Roytman specialize in?

While Dr. Marina M. Roytman is a Internal Medicine, they have specific expertise in Hepatitis, Non-Alcoholic Fatty Liver Disease, and Nonalcoholic Steatohepatitis (NASH). MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Internal Medicine.

Does Dr. Marina M. Roytman participate in research or clinical trials?

Yes. Dr. Marina M. Roytman has published 52 articles and abstracts on conditions like Hepatitis. You can view a list of Dr. Marina M. Roytman's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Marina M. Roytman accept my insurance?

Dr. Marina M. Roytman accepts most major insurance plans, including Aetna and Alignment Health Plan. We recommend calling the office directly at 866-342-6012 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Roytman's expertise for a condition
ConditionClose
View All 10 Distinguished Conditions
View All 16 Advanced Conditions
View All 35 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile